The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for inhibiting or treating inflammatory lung disease by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.
Issue/Publication date:
10/25/2011
There are no reviews yet.
Be the first to review “Method Of Treating Inflammatory Lung Disease With Suppressors Of Cpg Oligonucleotides” Cancel reply
There are no reviews yet.